NAL, a new metric for assessing the immunotherapy response, showed a negative correlation with high KCNH2 expression in COAD, COAD/rectum adenocarcinoma oesophageal carcinoma (COADREAD), and UCEC (Fig. 6). Here, KCNH2 is linked to rectum adenocarcinoma.